Peter Kuhn Selected Research

COVID-19

4/2023

Investigation of liquid biopsy analytes in peripheral blood of individuals after SARS-CoV-2 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Kuhn Research Topics

Disease

53	Neoplasms (Cancer) 02/2024 - 02/2006
17	Circulating Neoplastic Cells 01/2024 - 02/2012
16	Prostatic Neoplasms (Prostate Cancer) 08/2023 - 07/2008
9	Breast Neoplasms (Breast Cancer) 08/2023 - 01/2012
7	Retinoblastoma (Glioblastoma, Retinal) 05/2023 - 11/2018
6	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2012
6	Body Weight (Weight, Body) 08/2018 - 03/2009
4	Disease Progression 12/2023 - 03/2018
4	Neoplasm Metastasis (Metastasis) 06/2022 - 11/2010
4	Carcinogenesis 06/2022 - 09/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 07/2014
4	Infections 11/2010 - 06/2007
3	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 12/2012
3	Necrosis 12/2019 - 03/2012
3	Inflammation (Inflammations) 01/2018 - 04/2010
3	Weight Gain 08/2015 - 02/2013
3	Insulin Resistance 06/2015 - 01/2014
3	Hyperglycemia 01/2014 - 05/2009
3	Severe Acute Respiratory Syndrome 02/2009 - 04/2008
2	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 11/2022
2	Multiple Myeloma 10/2023 - 09/2023
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022 - 01/2019
2	Adenocarcinoma 01/2016 - 07/2008
2	Thrombosis (Thrombus) 01/2016 - 02/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 02/2012
2	Obesity 08/2015 - 06/2015
2	Fatty Liver 06/2015 - 07/2014
2	Type 2 Diabetes Mellitus (MODY) 12/2012 - 03/2009
2	Stress Urinary Incontinence 06/2011 - 11/2006
2	Urinary Incontinence 01/2009 - 11/2006
1	COVID-19 04/2023
1	Plasma Cell Neoplasms 11/2022
1	Uveal melanoma 06/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Monoclonal Gammopathy of Undetermined Significance 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Retinal Detachment (Retinal Detachments) 07/2021
1	Chromosomal Instability (Chromosome Stability) 07/2021
1	Genomic Instability 01/2020

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2013
16	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2006
12	Cell-Free Nucleic AcidsIBA 11/2023 - 11/2017
10	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 09/2009
7	Glucose (Dextrose)FDA LinkGeneric 08/2018 - 12/2012
6	Keratins (Keratin)IBA 01/2024 - 02/2012
5	PolyphenolsIBA 01/2018 - 02/2013
4	DAPIIBA 01/2024 - 08/2014
4	TFXIBA 11/2023 - 01/2020
4	NucleotidesIBA 11/2023 - 12/2020
4	Insulin (Novolin)FDA Link 11/2016 - 12/2012
4	LigandsIBA 01/2015 - 02/2006
3	Epithelial Cell Adhesion MoleculeIBA 08/2023 - 01/2013
3	Hormones (Hormone)IBA 01/2022 - 01/2017
3	Tumor Biomarkers (Tumor Markers)IBA 03/2021 - 08/2014
3	Androgen Receptors (Androgen Receptor)IBA 12/2020 - 02/2012
3	EphrinsIBA 01/2015 - 02/2006
3	Hypoglycemic Agents (Hypoglycemics)IBA 07/2014 - 03/2009
2	ProteomeIBA 09/2023 - 04/2008
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2017
2	Acetates (Acetic Acid Esters)FDA Link 01/2019 - 01/2017
2	LipopolysaccharidesIBA 11/2016 - 08/2015
2	LipidsIBA 11/2016 - 07/2014
2	Thromboplastin (Tissue Factor)IBA 01/2016 - 02/2015
2	Eph Family Receptors (Eph Receptors)IBA 01/2015 - 12/2007
2	CholesterolIBA 02/2013 - 04/2003
2	Phosphotransferases (Kinase)IBA 12/2007 - 02/2006
1	brexucabtagene autoleucelIBA 02/2024
1	Chimeric Antigen ReceptorsIBA 02/2024
1	axicabtagene ciloleucelIBA 02/2024
1	VimentinIBA 01/2024
1	Immunologic Factors (Immunomodulators)IBA 12/2023
1	Bortezomib (Velcade)FDA Link 10/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023
1	AmbarIBA 10/2023
1	Calcibiotic Root Canal SealerIBA 08/2023
1	diazonaphthalenedisulfonic acid (NDS)IBA 04/2023
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 11/2022
1	B-Cell Maturation AntigenIBA 11/2022
1	neratinibIBA 02/2022
1	Everolimus FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2022
1	Fulvestrant (Faslodex)FDA Link 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	cabazitaxel FDA Link 12/2021
1	Carboplatin (JM8)FDA LinkGeneric 12/2021
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	enzalutamideIBA 12/2020
1	Sorafenib (BAY 43-9006)FDA Link 12/2020
1	ParaffinIBA 01/2020

Therapy/Procedure

21	Therapeutics 11/2023 - 09/2006
7	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
4	Castration 12/2021 - 01/2017
2	Cystectomy 02/2022 - 01/2019
2	Oral Administration 01/2014 - 04/2010
1	Operative Surgical Procedures 02/2024
1	Immunomodulation 12/2023
1	Oncolytic Virotherapy 10/2023
1	Aftercare (After-Treatment) 01/2020
1	Fitness Trackers 01/2020